Prostate Cancer
Impact of Additional Active Treatment for Prostate Cancer on Health-related Quality of Life of Men: Results from the EUPROMS 2.0 1-year Follow-up Survey.
January 20, 2025
Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men.
January 20, 2025
Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review.
January 20, 2025
Evaluating the feasibility of AI-predicted bpMRI image features for predicting prostate cancer aggressiveness: a multi-center study.
January 20, 2025
Racial Differences in Survival and Healthcare Resource Utilization Among Medicaid-Insured Adults With Metastatic Prostate Cancer.
January 17, 2025
Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy.
January 17, 2025
Cost-Effectiveness of PARP Inhibitors for Patients with BRCA1/2-Positive Metastatic Castration-Resistant Prostate Cancer-The Canadian Perspective.
January 16, 2025
Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations.
January 16, 2025
The interaction of structured data using openEHR and large Language models for clinical decision support in prostate cancer.
January 16, 2025
Impact of Endorectal Coil Use on Extraprostatic Extension Detection in Prostate MRI: A Retrospective Monocentric Study.
January 16, 2025
An Overview of Patient-reported Outcomes for Men with Prostate Cancer: Results from the PIONEER Consortium.
January 15, 2025